President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Investigational treatment improves outcomes without complete complement blockade ...

ARCHER II Topline Pivotal Phase 3 Data in Geographic Atrophy (GA) Expected Q4 2026; Vonaprument has Potential to Be the First Vision-Preserving Therapy for GA Tanruprubart MAA Filed in Europe with ...

Discover large garden ideas to give your outdoor space more beauty and functionality. Think: pathways, trellises, raised beds ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

D-Wave Quantum stock gains attention amid institutional activity and quantum computing developments. Explore key drivers ...

Last October, commuters travelling along ­Craigflower Road might have noticed the­ ­sudden disappearance of a familiar ...

Detailed price information for Intl Business Machines (IBM-N) from The Globe and Mail including charting and trades.

The New England Botanic Garden at Tower Hill in Boylston is the kind of place that makes you wonder what else you’ve been ...

Prickly pear (Opuntia ficus-indica) is increasingly studied for its antioxidant and anti-inflammatory properties. The extract in NeuroSalt is standardized at a 20:1 concentration ratio, meaning it's ...